An Analysis of Financial Performance of Pharmaceutical Industry in India - A Study on NSE Listed Pharmaceutical Companies
##plugins.themes.academic_pro.article.main##
Abstract
When the economy of entire world has been shattered by the sudden strike of Covid-19 Pandemic, Indian economy is still running with the help of Pharmaceutical Industry. It acts as a strong backbone of the economy. According to IKON Marketing Consultants! estimates, in the fiscal year, 2020-21 the Indian pharma industry is estimated to be worth $43 billion. In the last fiscal itself, the sector contributed around 1.72 per cent to the country’s GDP, making a significant mark. It was around one per cent a decade ago. In the case of exports, drugs and pharma products have recorded positive growth of 24.89 per cent during September 2020 vis-a-vis September 2019 amongst a few other commodity groups. The export of pharma products stood at $ 7,595 million and it remains the second-highest contributor with 7.79 per cent of total exports during April — Aug 2020, the Ist first being minerals with 8.94 per cent. Therefore, this study analyzes the present scenario of Indian Pharmaceutical Industry in terms of their financial performance.
##plugins.themes.academic_pro.article.details##
References
- Banerji Amit and Suri Khan Feroz. (2017). Patents, R&D Expenditure, Regulatory Filings and Exports in Indian Pharmaceutical Industry. Journal of Intellectual Property Rights, 22, pp. 136-145.
- Bhunia Amalendu. (2010). Financial Performance of Indian Pharmaceutical Industry —A Case Study. Asian Journal of Management Research. pp 427-451.
- Dhanalaksmi C. (2017). Growth of Indian Pharmaceutical Industry: An Overview. International Journal of Multidisciplinary Research Hub. pp 6-12.
- Fernandes Nuno. [2020]. Economic Effects of Corona virus Outbreak (Covid- 19) on the World Economy. Accessed on May 28, 2020 from the link-https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3557504 or available at SSRN http://dx.doi.org/10.2139/ssrn.3557504 DOI: https://doi.org/10.2139/ssrn.3557504
- Geethalakshmi A. and Jothi k. (2016). A Study on Profitability Position of Pharmaceutical Industry in India. International Journal of Advance Research in Computer Science and Management Studies. Volume -4, Issue-4. April, 2016. Page: 181-188.
- Gopalkrishnan Muthu M., Satish J.A., Reddy Prakash A. and Krishna Rama U. (2016). Analysis of Financial Performance of Pharmaceutical Companies Using Z Score Model. Shanlax International Journal of Management. 4(2), pp 93-100.
- Jalaudeen A. and Marimuthu M. (2019). Financial Strength and Weakness of Selected Pharmaceutical Companies in India, International Journal of Recent Technology and Engineering.8(4) pp 8128. DOI: https://doi.org/10.35940/ijrte.D1190.1284S219
- Jamwal Anbesh, Bhatnagar Sumedha and Sharma Prakarti. [2020]. Coronavirus Disease 2019 (COVID — 19): Current literature and Status in India. Preprints 2020, 2020040189. DOI: 10.20944/preprints202004.0189.v1 DOI: https://doi.org/10.20944/preprints202004.0189.v1
- Kiran Ravi and Mishra Sunita. (2008). Performance of the Indian Pharmaceutical Industry in Post-TRIPS Period: A Firm Level Analysis. International Review of Business Research Papers. 5(6) pp 148-160.
- Manju and Sharma Vipin. (2020). An Analysis of Exports Performance of Indian Pharmaceutical Industry during Pre and Post — TRIPS Period. PalArch's Journal of Archaeology of Egypt.
- Vijayalakshmi V. and Srividya M. (2014). A Study on Financial Performance of Pharmaceutical Industry in India. Journal of Management and Science. 4(3)pp 36-54.